Cargando…
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
Triple-negative breast cancer is the most aggressive subtype of breast cancer and is difficult to treat. Breast cancer is considered to be poorly immunogenic and hence is less responsive to immunotherapies. We tested whether the oncolytic poxvirus CF33-hNIS-ΔF14.5 could modulate tumor immune microen...
Autores principales: | Chaurasiya, Shyambabu, Yang, Annie, Kang, Seonah, Lu, Jianming, Kim, Sang-In, Park, Anthony K., Sivanandam, Venkatesh, Zhang, Zhifang, Woo, Yanghee, Warner, Susanne G., Fong, Yuman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051185/ https://www.ncbi.nlm.nih.gov/pubmed/32158622 http://dx.doi.org/10.1080/2162402X.2020.1729300 |
Ejemplares similares
-
An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2023) -
A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
por: Warner, Susanne G., et al.
Publicado: (2019) -
A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021) -
PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1
por: Zhang, Zhifang, et al.
Publicado: (2021) -
Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients
por: Zhang, Zhifang, et al.
Publicado: (2023)